{"disease":{"id":"dementia-of-alzheimer-type","name":"dementia of alzheimer type"},"drugs":{"marketed":[{"drug_id":"donepezil-hydrochloride","indication_name":"Dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DONEPEZIL HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":28,"revenue":null,"mechanism":null},{"drug_id":"galantamine","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Razadyne","generic_name":"GALANTAMINE","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":62,"revenue":null,"mechanism":"Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain."},{"drug_id":"galantamine-hydrobromide","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GALANTAMINE HYDROBROMIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":31,"revenue":null,"mechanism":null},{"drug_id":"benzgalantamine","indication_name":"mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zunveyl","generic_name":"BENZGALANTAMINE","company_name":"Alpha Cognition","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":56,"revenue":null,"mechanism":"Zunveyl works by enhancing communication between brain cells, specifically by stimulating cholinergic receptors."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05796037","title":"An Observational Study of Patients Living With Chronic Neurological Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500000,"lead_sponsor_name":"Target PharmaSolutions, Inc.","has_results":false},{"nct_id":"NCT06719453","title":"Prevalence of Alzheimer's Disease Pathology in the Community","phase":"","overall_status":"COMPLETED","enrollment_count":9663,"lead_sponsor_name":"Helse Stavanger HF","has_results":false},{"nct_id":"NCT04680013","title":"Genetic Studies in Familial Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":4884,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT02446132","title":"Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1197,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT05052450","title":"Factors Associated With Mortality, Morbidity and Prognosis in Dementia Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Gulhane Training and Research Hospital","has_results":false},{"nct_id":"NCT03393520","title":"Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":601,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT04488419","title":"ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":554,"lead_sponsor_name":"LeonaBio","has_results":true},{"nct_id":"NCT05893524","title":"Uppsala-Dalarna Dementia and Gait Project","phase":"","overall_status":"RECRUITING","enrollment_count":550,"lead_sponsor_name":"Dalarna University","has_results":false},{"nct_id":"NCT04863495","title":"Couples Lived Experience","phase":"","overall_status":"COMPLETED","enrollment_count":544,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT02442778","title":"Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":522,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04947553","title":"A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05923307","title":"Multifactorial Approach to Dementia, Multicentric Study","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"Daniel Serrani Azcurra","has_results":false},{"nct_id":"NCT04428112","title":"Rural Dementia Caregiver Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":418,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT03620981","title":"Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":410,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT05557409","title":"A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":408,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02442765","title":"Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":387,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03226522","title":"Addressing Dementia Via Agitation-Centered Evaluation","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05973448","title":"The Nightlight Falls Prevention Study","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":335,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT03875326","title":"Stimulation to Improve Memory","phase":"NA","overall_status":"COMPLETED","enrollment_count":269,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT04464564","title":"Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":241,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04408755","title":"Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":184,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04797715","title":"Assessing Clinical Outcomes in Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03724942","title":"Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT04851691","title":"An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions","phase":"NA","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT02168920","title":"Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":150,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04956549","title":"Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)","phase":"NA","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"Pennington Biomedical Research Center","has_results":false},{"nct_id":"NCT06736509","title":"An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":139,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05860127","title":"Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"University of Massachusetts, Amherst","has_results":true},{"nct_id":"NCT06292351","title":"DMB-I in the Treatment of Alzheimer Type Dementia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"Bigespas LTD","has_results":false},{"nct_id":"NCT05394584","title":"CST-HK for Cognition and Well-being in People With Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT04969796","title":"REACH Hope Intervention for Dementia and TBI Caregivers","phase":"NA","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Memphis VA Medical Center","has_results":false},{"nct_id":"NCT05232526","title":"Imagery in Early Stages of Dementia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":105,"lead_sponsor_name":"University of West Attica","has_results":false},{"nct_id":"NCT04491006","title":"A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"LeonaBio","has_results":true},{"nct_id":"NCT07010874","title":"THE EFFECT OF REMOTE NURSING INTERVENTIONS BASED ON THE EMPOWERMENT PROCESS MODEL ON PEOPLE WITH DEMENTIA AND THEIR FAMILY CAREGIVERS","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Gazi University","has_results":false},{"nct_id":"NCT03875638","title":"Treating Hyperexcitability in AD With Levetiracetam","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT05516134","title":"All About Me: An Intervention to Ease the Transition to Long Term Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Hopeful Aging","has_results":true},{"nct_id":"NCT05524181","title":"Telehealth-enabled Integrated Palliative Care for People With Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT04682535","title":"Daily Study of Caregiving Relationships and Health","phase":"","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"The University of Texas Health Science Center at San Antonio","has_results":false},{"nct_id":"NCT04828434","title":"Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04555629","title":"Advanced Cognitive Stimulation Therapy Hong Kong (ACST-HK)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04550975","title":"Advanced Cognitive Stimulation Therapy (ACST)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT05336695","title":"Assess Fibrin in Brains With AD/ADRD","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT02549196","title":"A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Chase Pharmaceuticals Corporation, an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT02434666","title":"Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Chase Pharmaceuticals Corporation, an affiliate of Allergan plc","has_results":false},{"nct_id":"NCT06378372","title":"How Does Pianistic Musical Training Influence the Development of Alzheimer's Disease?","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"David Franco Castellanos","has_results":false},{"nct_id":"NCT04313582","title":"Feasibility of the SmartPrompt for Improving Everyday Function in Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Temple University","has_results":false},{"nct_id":"NCT04240561","title":"Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04315337","title":"Improving Everyday Task Performance Through Repeated Practice in Virtual Reality.","phase":"NA","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Temple University","has_results":false},{"nct_id":"NCT04749563","title":"Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"IGC Pharma, LLC","has_results":false}],"total":49},"guidelines":[],"source":"Drug Landscape verified database"}